Px203 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Px203 . Real-time updates on events, politics, business and more.

Knight Therapeutics Inks License Agreement With Amneal Pharma For IPX203

January 25, 2024

Specialty pharmaceutical company Knight Therapeutics Inc. (GUD.TO) announced Thursday it has entered into an exclusive license agreement with Amneal Pharmaceuticals, Inc.

Humana Inc Aviation Administration Nokia Corp Medicare Advantage Federal Aviation Administration Amneal Pharmaceuticals

Source: rttnews.com

Amneal Tumble Over 15% In Pre-market As FDA Seeks Addl. Info On NDA For IPX203

July 5, 2023

Shares of Amneal Pharmaceuticals, Inc. (AMRX) are trading down on Wednesday morning after the company announced that the FDA sought additional information on the New Drug Application for IPX203 to treat Parkinson's disease.

Amneal Pharmaceuticals Inc York Stock Exchange New York Stock Exchange Amneal Pharmaceuticals New Drug Application New York Stock

Source: rttnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Px203 News Today

Knight Therapeutics Inks License Agreement With Amneal Pharma For IPX203

Amneal Tumble Over 15% In Pre-market As FDA Seeks Addl. Info On NDA For IPX203

Explore More Categories